Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prime-Boost SARS-CoV-2 Vaccination in Cancer Patients
NCT05273541Phase 2Unknown
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- Feb 2022
- Primary completion
- Dec 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of SARS-CoV-2 vaccine in coronavirus disease 2019 (COVID-19), sponsored by The Fifth Medical Center of the PLA General Hospital. Status: unknown.
02
Drugs
SARS-CoV-2 vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05273541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05273541.